Oppenheimer Lowers Bioceres Crop Solutions (NASDAQ:BIOX) Price Target to $13.00

Bioceres Crop Solutions (NASDAQ:BIOX) had its target price lowered by investment analysts at Oppenheimer from $16.00 to $13.00 in a research report issued to clients and investors on Monday, Benzinga reports. The firm presently has an “outperform” rating on the stock. Oppenheimer’s price target would suggest a potential upside of 79.06% from the company’s current price.

Other research analysts have also issued research reports about the company. Canaccord Genuity Group raised Bioceres Crop Solutions to a “strong-buy” rating in a report on Friday, July 19th. Canaccord Genuity Group lowered their target price on Bioceres Crop Solutions from $12.50 to $10.00 and set a “buy” rating on the stock in a report on Thursday, October 17th. Lake Street Capital lowered their target price on Bioceres Crop Solutions from $25.00 to $13.00 and set a “buy” rating on the stock in a report on Wednesday, September 11th. Roth Mkm lowered their target price on Bioceres Crop Solutions from $15.00 to $13.00 and set a “buy” rating on the stock in a report on Wednesday, September 11th. Finally, Roth Capital upgraded Bioceres Crop Solutions to a “strong-buy” rating in a research report on Tuesday, July 2nd. Four investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, Bioceres Crop Solutions presently has a consensus rating of “Buy” and a consensus price target of $12.25.

Bioceres Crop Solutions Trading Down 2.2 %

NASDAQ:BIOX opened at $7.26 on Monday. The firm has a market cap of $455.91 million, a P/E ratio of 726.00 and a beta of 0.47. The company has a current ratio of 1.28, a quick ratio of 0.91 and a debt-to-equity ratio of 0.35. The stock’s 50 day simple moving average is $8.81 and its 200-day simple moving average is $10.43. Bioceres Crop Solutions has a 12-month low of $7.15 and a 12-month high of $14.05.

Bioceres Crop Solutions (NASDAQ:BIOX) last announced its quarterly earnings data on Monday, September 9th. The company reported ($0.03) earnings per share for the quarter, missing analysts’ consensus estimates of $0.20 by ($0.23). Bioceres Crop Solutions had a return on equity of 0.93% and a net margin of 0.68%. The business had revenue of $124.30 million for the quarter, compared to analyst estimates of $126.75 million. During the same period in the prior year, the company earned ($0.06) EPS. Equities analysts anticipate that Bioceres Crop Solutions will post 0.39 EPS for the current year.

Institutional Investors Weigh In On Bioceres Crop Solutions

Several hedge funds have recently made changes to their positions in the business. Wellington Management Group LLP raised its position in shares of Bioceres Crop Solutions by 3.1% in the 4th quarter. Wellington Management Group LLP now owns 236,906 shares of the company’s stock worth $3,253,000 after buying an additional 7,096 shares during the period. Oppenheimer & Co. Inc. purchased a new position in Bioceres Crop Solutions in the first quarter valued at about $139,000. Lazard Asset Management LLC purchased a new position in Bioceres Crop Solutions in the first quarter valued at about $212,000. Sumitomo Mitsui Trust Holdings Inc. purchased a new position in Bioceres Crop Solutions in the second quarter valued at about $472,000. Finally, Oak Family Advisors LLC raised its position in Bioceres Crop Solutions by 1.9% in the second quarter. Oak Family Advisors LLC now owns 64,925 shares of the company’s stock valued at $728,000 after purchasing an additional 1,208 shares during the period. Institutional investors and hedge funds own 17.68% of the company’s stock.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.